315 related articles for article (PubMed ID: 14658991)
1. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
[TBL] [Abstract][Full Text] [Related]
2. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
[TBL] [Abstract][Full Text] [Related]
3. Intensive treatment of dysarthria secondary to stroke.
Mahler LA; Ramig LO
Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Lee Silverman Voice Treatment (LSVT) on hypernasality in non-progressive dysarthria: the need for further research.
Wenke RJ; Theodoros D; Cornwell P
Int J Lang Commun Disord; 2010; 45(1):31-46. PubMed ID: 19565392
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of intensive voice treatment (LSVT LOUD
Boliek CA; Fox CM
Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
[TBL] [Abstract][Full Text] [Related]
6. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.
Wenke RJ; Cornwell P; Theodoros DG
Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339
[TBL] [Abstract][Full Text] [Related]
7. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
8. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria.
Fox CM; Boliek CA
J Speech Lang Hear Res; 2012 Jun; 55(3):930-45. PubMed ID: 22232407
[TBL] [Abstract][Full Text] [Related]
9. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
[TBL] [Abstract][Full Text] [Related]
10. The short- and long-term effectiveness of the LSVT for dysarthria following TBI and stroke.
Wenke RJ; Theodoros D; Cornwell P
Brain Inj; 2008 Apr; 22(4):339-52. PubMed ID: 18365848
[TBL] [Abstract][Full Text] [Related]
11. Intensive voice treatment (the Lee Silverman Voice Treatment [LSVT
Ertan E; Gürvit HI; Hanağası HH; Bilgiç B; Tunçer MA; Yılmaz C
Logoped Phoniatr Vocol; 2022 Dec; 47(4):262-270. PubMed ID: 34287100
[No Abstract] [Full Text] [Related]
12. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
[TBL] [Abstract][Full Text] [Related]
13. [The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)].
Kamińska I; Zebryk-Stopa A; Pruszewicz A; Dziubalska-Kołaczyk K; Połczyńska-Fiszer M; Pietrala D; Przedpelska-Ober E
Otolaryngol Pol; 2007; 61(5):713-8. PubMed ID: 18552005
[TBL] [Abstract][Full Text] [Related]
14. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
Sauvageau VM; Roy JP; Langlois M; Macoir J
Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
[TBL] [Abstract][Full Text] [Related]
15. Intensive Voice Treatment (Lee Silverman Voice Treatment [LSVT LOUD]) for Children With Down Syndrome: Phase I Outcomes.
Boliek CA; Halpern A; Hernandez K; Fox CM; Ramig L
J Speech Lang Hear Res; 2022 Apr; 65(4):1228-1262. PubMed ID: 35230877
[TBL] [Abstract][Full Text] [Related]
16. Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.
Baldanzi C; Crispiatico V; Foresti S; Groppo E; Rovaris M; Cattaneo D; Vitali C
J Voice; 2022 Jul; 36(4):585.e1-585.e13. PubMed ID: 32819780
[TBL] [Abstract][Full Text] [Related]
17. Spectral/Cepstral Analyses of Phonation in Parkinson's Disease before and after Voice Treatment: A Preliminary Study.
Alharbi GG; Cannito MP; Buder EH; Awan SN
Folia Phoniatr Logop; 2019; 71(5-6):275-285. PubMed ID: 31117110
[TBL] [Abstract][Full Text] [Related]
18. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
[TBL] [Abstract][Full Text] [Related]
19. Voice in Friedreich Ataxia.
Vogel AP; Wardrop MI; Folker JE; Synofzik M; Corben LA; Delatycki MB; Awan SN
J Voice; 2017 Mar; 31(2):243.e9-243.e19. PubMed ID: 27501923
[TBL] [Abstract][Full Text] [Related]
20. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
